Associated Papers
Shared genetics in epilepsy and migraine: A scoping review.
Sahu P et al.
Epileptic Disorders : International Epilepsy Journal With Videotape, 2025
Voltage-Gated Sodium Channel Dysfunctions in Neurological Disorders.
Barbieri R et al.
Life (basel, Switzerland), 2023
Gene variant effects across sodium channelopathies predict function and guide precision therapy.
Brunklaus A et al.
Brain : a Journal of Neurology, 2022
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Brunklaus A et al.
Brain : a Journal of Neurology, 2022
Epilepsy and Migraine Shared Genetic and Molecular Mechanisms: Focus on Therapeutic Strategies.
Gotra P et al.
Molecular Neurobiology, 2021
SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis.
Ding J et al.
Frontiers in Neurology, 2021
Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene.
Barbieri R et al.
The Journal of Headache and Pain, 2019
Two novel families with hemiplegic migraine caused by recurrent SCN1A mutation p.F1499L.
Schubert V et al.
Cephalalgia : an International Journal of Headache, 2018
Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders.
Sutherland HG et al.
Headache, 2017
Early-onset familial hemiplegic migraine due to a novel SCN1A mutation.
Fan C et al.
Cephalalgia : an International Journal of Headache, 2016
Two novel SCN1A mutations identified in families with familial hemiplegic migraine.
Weller CM et al.
Cephalalgia : an International Journal of Headache, 2014
Familial hemiplegic migraine due to L263V SCN1A mutation: discordance for epilepsy between two kindreds from Douro Valley.
Barros J et al.
Cephalalgia : an International Journal of Headache, 2014
Pearls and pitfalls in genetic studies of migraine.
Eising E et al.
Cephalalgia : an International Journal of Headache, 2013
Sodium overload due to a persistent current that attenuates the arrhythmogenic potential of a novel LQT3 mutation.
Moreau A et al.
Frontiers in Pharmacology, 2013
Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations.
Vahedi K et al.
Neurology, 2009